|
1
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Korn EL, Liu PY, Lee SJ, Chapman JA,
Niedzwiecki D, Suman VJ, Moon J, Sondak VK, Atkins MB, Eisenhauer
EA, et al: Meta-analysis of phase II cooperative group trials in
metastatic stage IV melanoma to determine progression-free and
overall survival benchmarks for future phase II trials. J Clin
Oncol. 26:527–534. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Velho TR: Metastatic melanoma - a review
of current and future drugs. Drugs Context.
2012:2122422012.PubMed/NCBI
|
|
4
|
Hagen B and Trinh VA: Managing side
effects of vemurafenib therapy for advanced melanoma. J Adv Pract
Oncol. 5:400–410. 2014.
|
|
5
|
Pierce GB and Wallace C: Differentiation
of malignant to benign cells. Cancer Res. 31:127–134.
1971.PubMed/NCBI
|
|
6
|
Pierce GB: The cancer cell and its control
by the embryo. Rous-Whipple Award lecture. Am J Pathol.
113:117–124. 1983.PubMed/NCBI
|
|
7
|
Wang ZY and Chen Z: Acute promyelocytic
leukemia: From highly fatal to highly curable. Blood.
111:2505–2515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marcucci G, Haferlach T and Döhner H:
Molecular genetics of adult acute myeloid leukemia: Prognostic and
therapeutic implications. J Clin Oncol. 29:475–486. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu JL, Li J, Zhou ZH, Liu JR, Huang BH,
Zheng D and Su C: Differentiation induction enhances bortezomib
efficacy and overcomes drug resistance in multiple myeloma. Biochem
Biophys Res Commun. 420:644–650. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu ZZ, Zhu J, Sun B, Liu S, Geng S, Liu X
and Li CL: Alternol inhibits proliferation and induces apoptosis in
mouse lymphocyte leukemia (L1210) cells. Mol Cell Biochem.
306:115–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu XL, Wang YL, Chen JP, Duan LL, Cong
PF, Qu YC, Li-Ling J and Zhang MX: Alternol inhibits migration and
invasion of human hepatocellular carcinoma cells by targeting
epithelial-to-mesenchymal transition. Tumour Biol. 35:1627–1635.
2014. View Article : Google Scholar
|
|
12
|
Liu X, Wang J, Sun B, Zhang Y, Zhu J and
Li C: Cell growth inhibition, G2M cell cycle arrest, and apoptosis
induced by the novel compound Alternol in human gastric carcinoma
cell line MGC803. Invest New Drugs. 25:505–517. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yeung ED, Morrison A, Plumeri D, Wang J,
Tong C, Yan X and Li J: Alternol exerts prostate-selective
antitumor effects through modulations of the AMPK signaling
pathway. Prostate. 72:165–172. 2012. View Article : Google Scholar
|
|
14
|
Liu L, Zhang B, Yuan X, Wang P, Sun X and
Zheng Q: Alternol induces an S-phase arrest of melanoma B16F0
cells. Cell Biol Int. 38:374–380. 2014. View Article : Google Scholar
|
|
15
|
Tang Y, Chen R, Huang Y, Li G, Huang Y,
Chen J, Duan L, Zhu BT, Thrasher JB, Zhang X, et al: Natural
compound Alternol induces oxidative stress-dependent apoptotic cell
death preferentially in prostate cancer cells. Mol Cancer Ther.
13:1526–1536. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edward M, Gold JA and MacKie RM: Different
susceptibilities of melanoma cells to retinoic acid-induced changes
in melanotic expression. Biochem Biophys Res Commun. 155:773–778.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghattas S, Howle J, Wang W, Kefford R and
Gruenewald S: Intravascular metastatic melanoma: A difficult
diagnosis. Australas J Dermatol. 54:141–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakaya K, Nabata Y, Ichiyanagi T and An
WW: Stimulation of dendritic cell maturation and induction of
apoptosis in leukemia cells by a heat-stable extract from azuki
bean (Vigna angularis), a promising immunopotentiating food and
dietary supplement for cancer prevention. Asian Pac J Cancer Prev.
13:607–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Macfarlane DE and Manzel L: Activation of
beta-isozyme of protein kinase C (PKC beta) is necessary and
sufficient for phorbol ester-induced differentiation of HL-60
promyelocytes. Studies with PKC beta-defective PET mutant. J Biol
Chem. 269:4327–4331. 1994.PubMed/NCBI
|
|
20
|
Liu YH, Gao XM, Ge FM, Wang Z, Wang WQ and
Li XY: PBK/TOPK expression during TPA-induced HL-60 leukemic cell
differentiation. Asian Pac J Cancer Prev. 13:2145–2148. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng R, Wang SM, Yin T, Ye TH, Shen GB, Li
L, Zhao JY, Sang YX, Duan XG and Wei YQ: Dimethyl sulfoxide
suppresses mouse 4T1 breast cancer growth by modulating
tumor-associated macrophage differentiation. J Breast Cancer.
17:25–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sulaimon SS and Kitchell BE: The biology
of melanocytes. Vet Dermatol. 14:57–65. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin JY and Fisher DE: Melanocyte biology
and skin pigmentation. Nature. 445:843–850. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Costin GE and Hearing VJ: Human skin
pigmentation: Melanocytes modulate skin color in response to
stress. FASEB J. 21:976–994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hearing VJ and Jiménez M: Analysis of
mammalian pigmentation at the molecular level. Pigment Cell Res.
2:75–85. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hearing VJ and Tsukamoto K: Enzymatic
control of pigmentation in mammals. FASEB J. 5:2902–2909.
1991.PubMed/NCBI
|
|
27
|
Valverde P, Garcia-Borron JC,
Jimenez-Cervantes C, Solano F and Lozano JA: Tyrosinase isoenzymes
in mammalian melanocytes. 2. Differential activation by
α-melanocyte-stimulating hormone. Eur J Biochem. 217:541–548. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang CX, Zhang B, Chen N, Liu LL, Liu JL,
Wang Q, Wang ZH, Sun XL and Zheng QS: Alteronol induces
differentiation of melanoma B16F0 cells. Recent Patents Anticancer
Drug Discov. 210:116–117. 2015.
|
|
30
|
Yao J, Wu J, Yang X, Yang J, Zhang Y and
Du L: Oleuropein induced apoptosis in HeLa cells via a
mitochondrial apoptotic cascade associated with activation of the
c-Jun NH2-terminal kinase. J Pharmacol Sci. 125:300–311. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Huang CY, Zheng RL, Cui KR and Li
JF: Hydrogen peroxide induces apoptosis in human hepatoma cells and
alters cell redox status. Cell Biol Int. 24:9–23. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu L, Li T, Tan J, Fu J, Guo Q, Ji H and
Zhang Y: NG as a novel nitric oxide donor induces apoptosis by
increasing reactive oxygen species and inhibiting mitochondrial
function in MGC803 cells. Int Immunopharmacol. 23:27–36. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim SJ, Jun S, Cho HY, Lee DC, Yeom YI,
Kim JH and Kang D: Knockdown of anterior gradient 2 expression
extenuates tumor-associated phenotypes of SNU-478 ampulla of Vater
cancer cells. BMC Cancer. 14:8042014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo H, Wang Y, Song T, Xin T, Zheng Z,
Zhong P and Zhang X: Silencing of survivin using YM155 inhibits
invasion and suppresses proliferation in glioma cells. Cell Biochem
Biophys. 71:587–593. 2015. View Article : Google Scholar
|
|
35
|
Meyskens FL Jr and Fuller BB:
Characterization of the effects of different retinoids on the
growth and differentiation of a human melanoma cell line and
selected subclones. Cancer Res. 40:2194–2196. 1980.PubMed/NCBI
|
|
36
|
Hosoi J, Abe E, Suda T and Kuroki T:
Regulation of melanin synthesis of B16 mouse melanoma cells by 1
alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res.
45:1474–1478. 1985.PubMed/NCBI
|
|
37
|
Tomita Y, Maeda K and Tagami H:
Melanocyte-stimulating properties of arachidonic acid metabolites:
Possible role in postinflammatory pigmentation. Pigment Cell Res.
5:357–361. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ko HH, Tsai YT, Yen MH, Lin CC, Liang CJ,
Yang TH, Lee CW and Yen FL: Norartocarpetin from a folk medicine
Artocarpus communis plays a melanogenesis inhibitor without
cytotoxicity in B16F10 cell and skin irritation in mice. BMC
Complement Altern Med. 13:3482013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Choi YM, Jun HJ, Dawson K, Rodriguez RL,
Roh MR, Jun J, Choi CH, Shim JH, Lee CH, Lee SJ, et al: Effects of
the isoflavone puerarin and its glycosides on melanogenesis in B16
melanocytes. Eur Food Res Technol. 231:75–83. 2010. View Article : Google Scholar
|
